WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2013049174) SUBSTITUTED OCTAHYDROPYRROLO[1,2-A]PYRAZINE SULFONAMIDES AS CALCIUM CHANNEL BLOCKERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/049174    International Application No.:    PCT/US2012/057296
Publication Date: 04.04.2013 International Filing Date: 26.09.2012
Chapter 2 Demand Filed:    28.01.2013    
IPC:
C07D 487/04 (2006.01), A61K 31/4985 (2006.01), A61P 25/04 (2006.01)
Applicants: ABBVIE INC. [US/US]; 1 North Waukegan Road North Chicago, IL 60064 (US)
Inventors: LI, Tao; (US).
PATEL, Sachin, V.; (US).
PERNER, Richard, J.; (US).
RANDOLPH, John, T.; (US).
SCHRIMPF, Michael, R.; (US).
WOLLER, Kevin, R.; (US).
XIA, Zhiren; (US).
ZHANG, Qingwei; (US)
Agent: NENOW, Lydia, N.; 100 Abbott Park Road Abbott Park, IL 60064 (US).
WILLIAMS, Scott, A.; Armstrong Teasdale, LLP 7700 Forsyth Blvd. Suite 1800 St. Louis, Missouri 63105 (US)
Priority Data:
61/540,716 29.09.2011 US
Title (EN) SUBSTITUTED OCTAHYDROPYRROLO[1,2-A]PYRAZINE SULFONAMIDES AS CALCIUM CHANNEL BLOCKERS
(FR) OCTAHYDROPYRROLO[1,2-A]PYRAZINE SULFONAMIDES SUBSTITUÉS À TITRE D'INHIBITEURS DES CANAUX CALCIQUES
Abstract: front page image
(EN)The present application relates to: (a) compounds of Formula (I): (I), and salts thereof, wherein Z', Z", L2, G2, R1, and R2 are as defined in the specification; (b) compositions comprising such compounds and salts; and (c) methods of use of such compounds, salts, and compositions, particularly use as calcium channel blockers.
(FR)La présente demande concerne : (a) des composés de Formule (I) : (I), et leurs sels, Z', Z », L2, G2, R1, et R2 dans la Formule étant tels que définis dans la description ; (b) des compositions comprenant ces composés et ces sels ; et (c) des procédés d'utilisation desdits composés, sels, et compositions, en particulier, à titre d'inhibiteurs des canaux calciques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)